Company:  ALKERMES PLC. (ALKS)
Form Type:  8-K
Filing Date:  3/7/2012 
CIK:  0001520262 
Address:  CONNAUGHT HOUSE
1 BURLINGTON ROAD
 
City, State, Zip:  DUBLIN 4,  00000 
Telephone:  00-353-1-772-8000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$47.80  
Change: 
-0.91 (-1.87%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$6.91B
Description of Business
The following discussion contains forward-looking statements. Actual results may differ significantly from those projected in the forward-looking statements. See "Cautionary Note Concerning Forward-Looking Statements" on pages 3 and 4 of this Transition Report. Factors that might cause future results to differ materially from those projected in the forward-looking statements also include, but are not limited to, those discussed in "Item 1A�Risk Factors" and elsewhere in this Transition Report. Overview Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to research, develop and commercialize, both with partners and on our own, pharmaceutical products that are designed to address unmet medical needs of patients in major therapeutic areas.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into a Material Definitive Agreement
    SECTION 7 REGULATION FD
      Item 7.01. Regulation FD Disclosure
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits
    SIGNATURE
    EXHIBIT INDEX
  EXHIBIT 10.1
  EXHIBIT 99.1
BROKERAGE PARTNERS